Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction

https://doi.org/10.1016/S0960-0760(96)00100-8Get rights and content

Abstract

The expression of aromatase in human breast tumors has been studied by the reverse-transcription polymerase chain reaction (RT-PCR) method on 70 breast tissue specimens. An RT-PCR analysis using two oligonucleotide primers derived from the exon II of the human aromatase gene revealed that aromatase mRNA was detected in all but three tissue specimens. Furthermore, primer-directed RT-PCR was performed to determine the exon I usage in aromatase mRNA in these breast tumor specimens. The analysis has revealed that exons I.3 and PII are the two major exon Is present in aromatase mRNA isolated from breast tumors, suggesting that promoters I.3 and II are the major promoters driving aromatase expression in breast cancer and surrounding adipose stromal cells. The RT-PCR analysis also detected two products, I.3A (334 bp in length) and I.3B (222 bp in length), when it was carried out using a primer derived from exon I.3 and a reverse primer derived from exon II. The nucleotide sequences of these products have been determined and indicate that I.3A contains a region which was previously thought to be an intron. In addition, RT-PCR analyses of RNA isolated from eight pairs of breast tumor and neighboring normal tissue specimens were performed to evaluate the exon I usage and the distribution of I.3A- and I.3B-containing aromatase RNA messages in breast tumor and neighboring normal tissues. The results suggest that I.3B- and I.3A-containing messages are mainly present in breast tumor and neighboring normal tissues, respectively. Finally, the exon I/promoter usage for aromatase expression in eight cell lines (skin fibroblast, MCF-7, MDA-MB-231, T-47D, SK-BR-3, JAR, OVCAR-3, and human adipose stromal cells) was examined by primer-directed RT-PCR analyses. These studies provide a basis for further evaluation of the control mechanism of aromatase expression and estrogen biosynthesis in breast tumors.

References (35)

  • J.O. Johnston et al.

    Time-dependent inhibition of aromatase in trophoblastic tumor cells in tissue culture

    J. Steroid Biochem.

    (1984)
  • J. Wang et al.

    Induction of aromatase gene expression in human placental choriocarcinoma (JAR) cells by phorbol esters

    Biochim. Biophys. Acta

    (1994)
  • M. Dowsett et al.

    Control of aromatase in breast cancer cells and its importance for tumor growth

    J. Steroid Biochem. Molec. Biol.

    (1993)
  • S.E. Bates et al.

    Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance

    Molec. Endocr.

    (1988)
  • S.E. Bulum et al.

    A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription

    J. Clin. Endocr. Metab.

    (1993)
  • H.L. Bradlow

    A reassessment of the role of breast tumor aromatization

    Cancer Res.

    (1982)
  • M.J. Reed et al.

    In situ oestrone synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxyandrostenedione

    Int. J. Cancer

    (1989)
  • Cited by (127)

    • Obesity and breast cancer – Role of estrogens and the molecular underpinnings of aromatase regulation in breast adipose tissue

      2018, Molecular and Cellular Endocrinology
      Citation Excerpt :

      As a result of the promoter switch, the regulation of estrogen production changes from one controlled primarily by glucocorticoids and cytokines to a regulation controlled by inflammatory factors. Some studies have confirmed predominance of PI.3/II usage over PI.4 in breast cancer tissues (Agarwal et al., 1996; Zhou et al., 1996). In addition to an increase in total aromatase mRNA levels in tumor tissue compared to breast normal tissue in a study conducted on 108 female samples, Irahara et al. reported that the percentage of promoter I.4 usage was significantly lower in tumor tissue than in normal breast tissue (Irahara et al., 2006).

    • Aromatase induction in tamoxifen-resistant breast cancer: Role of phosphoinositide 3-kinase-dependent CREB activation

      2014, Cancer Letters
      Citation Excerpt :

      Our findings imply that PI3K/Akt-dependent CREB activation is required for aromatase up-regulation in TAM-resistant breast cancer. Aromatase expression and estrogen levels are frequently elevated in breast cancer tissue compared to normal mammary tissue [11,34–37]. Up-regulation of aromatase is believed to stimulate breast cancer growth in either an autocrine or paracrine manner [38].

    • Aromatase, breast cancer and obesity: A complex interaction

      2012, Trends in Endocrinology and Metabolism
      Citation Excerpt :

      Thus, large numbers of estrogen-producing adipose fibroblasts are maintained proximal to malignant cells [43,68] (Figure 2). It has been demonstrated that the use of the proximal promoter I.3/II region accounts for the majority of in vivo aromatase expression in adipose tissue that is located adjacent to breast cancer, and in breast cancer tissue [24,45,46]. In vitro, treatment of undifferentiated adipose fibroblasts with cell-conditioned media derived from malignant breast epithelia was found to induce aromatase expression [43].

    • Growth factor signaling enhances aromatase activity of breast cancer cells via post-transcriptional mechanisms

      2011, Journal of Steroid Biochemistry and Molecular Biology
      Citation Excerpt :

      It has been proved that the estrogen concentration is much higher in the breast tumor tissue than it in the normal breast tissue. Several studies demonstrated that aromatase, the key enzyme for the biosynthesis of estrogen, is highly expressed in breast cancer tissue as quantified by RT-PCR [4,7,8,11]. Multiple factors attribute to the increase of aromatase expression, such as cytokines, growth factors and PGE2 produced by the COX enzyme at the cancer tissue.

    View all citing articles on Scopus
    View full text